[1] VIVEROS-CARRENO D,FERNANDES A,PAREJA R.Updates on cervical cancer preventions[J].Int J Gynecol Cancer,2023,33(3):394-402.
[2] SCHUBERT M,BAUERSCHLAG DO,MUALLEM MZ,et al.Challenges in the diagnosis and individualized treatment of cervical cancer[J].Medicina (Kaunas),2023,59(5):925.
[3] 白小英,曹蕾,张卫霞,等.LncRNA SNHG1通过miR-101-3p/MYLIP轴调节宫颈癌细胞增殖、凋亡和迁移的研究[J].中国计划生育和妇产科,2023,15(4):38-43,60,113.
BAI XY,CAO L,ZHANG WX,et al.LncRNA SNHG1 regulates the proliferation,apoptosis and migration of cervical cancer cells through the miR-101-3p/MYLIP axis[J].Chinese Journal of Family Planning and Gyneocotokolony,2023,15(4):38-43,60,113.
[4] HOU YM,WANG XP,SHEN CC,et al.Cervical carcinoma progression is aggravated by lncRNA ZNF281 by binding KLF15[J].Eur Rev Med Pharmacol Sci,2021,25(18):5610-5618.
[5] ZHANG M,WANG N,SONG P,et al.LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1[J].Cell Prolif,2020,53(9):e12855-e12868.
[6] LIU YX,YUAN S,LIU XJ,et al.LncRNA GATA3-AS1 promoted invasion and migration in human endometrial carcinoma by regulating the miR-361/ARRB2 axis[J].J Mol Med (Berl),2022,100(9):1271-1286.
[7] ALI SYEDA Z,LANGDEN SSS,MUNKHZUL C,et al.Regulatory mechanism of microrna expression in cancer[J].Int J Mol Sci,2020,21(5):1723-1741.
[8] WANG D,WANG H,LI Y,et al.MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma[J].Biosci Rep,2018,3 8(3):1-9.
[9] DOGHISH AS,ALI MA,ELYAN SS,et al.miRNAs role in cervical cancer pathogenesis and targeted therapy:Signaling pathways interplay[J].Pathol Res Pract,2023,244(5):154386-154398.
[10] CHEN P,ZHANG W,CHEN Y,et al.Comprehensive analysis of aberrantly expressed long non-coding RNAs,microRNAs,and mRNAs associated with the competitive endogenous RNA network in cervical cancer[J].Mol Med Rep,2020,22(1):405-415.
[11] LIU Y,XU G,LI L.LncRNA GATA3-AS1-miR-30b-5p-Tex10 axis modulates tumorigenesis in pancreatic cancer[J].Oncol Rep,2021,45(5):59-69.
[12] LIN S,ZHAO M,LV Y,et al.The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway[J].Aging (Albany NY),2021,13(10):13663-13679.
[13] CHEN X,XIE L,QIAO K,et al.The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer[J].Aging (Albany NY),2023,15(3):689-704.
[14] AZEVEDO MARTINS JM,RABELO-SANTOS SH,DO AMARAL WESTIN MC,et al.Tumoral and stromal expression of MMP-2,MMP-9,MMP-14,TIMP-1,TIMP-2,and VEGF-A in cervical cancer patient survival:a competing risk analysis[J].BMC Cancer,2020,20(1):660-671.
[15] 曹琼,代爱军,李宜川,等.miRNA-1靶向DDX5抑制食管癌细胞增殖、迁移及侵袭[J].现代肿瘤医学,2020,28(05):702-705.
CAO Qiong,DAI Aijun,LI Yichuan,et al.miRNA-1 inhibits proliferation,migration,and invasion of esophageal cancer cells by targeting DDX5[J].Modern Oncology,2020,28(05):702-705.
[16] 李永红,刘伟仪,李伟,等.miRNA-184在胶质瘤组织中的表达及其对胶质瘤细胞增殖和凋亡的影响[J].现代肿瘤医学,2020,28(14):2385-2389.
LI Yonghong,LIU Weiyi,LI Wei,et al.Expression of miRNA-184 in glioma tissues and its effect on glioma cells proliferation and apoptosis[J].Modern Oncology,2020,28(14):2385-2389.
[17] LI C,YANG Y,WANG H,et al.miR-362-3p suppresses ovarian cancer by inhibiting LRP8[J].Transl Oncol,2022,15(1):101284-101293.
[18] ASSIRI AA,MOURAD N,SHAO M,et al.MicroRNA 362-3p reduces hERG-related current and inhibits breast cancer cells proliferation[J].Cancer Genomics Proteomics,2019,16(6):433-442.
[19] YANG S,ZHANG X,SUN Y,et al.MicroRNA-362-3p inhibits migration and invasion via targeting BCAP31 in cervical cancer[J].Front Mol Biosci,2020,7(1):107-118.
[20] ZHANG Y,LUO M,CUI X,et al.Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA[J].Cell Death Differ,2022,29(9):1850-1863.
[21] XIE B,WANG Z,LI T,et al.LncRNA MALAT1 inhibits the proliferation and invasiveness of laryngeal squamous cell carcinoma Hep-2 cells by modulating miR-362-3p[J].Am J Transl Res,2022,14(6):3729-3740.
[22] WANG W,JIA HL,HUANG JM,et al.Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics[J].Br J Cancer,2014,110(7):1748-1758.